At Clemenceau Medical Center Hospital Dubai our Endocrinologists are experts in assessing and consulting on the appropriate use of Mounjaro Injection. Mounjaro is considered a game-changer in the treatment of type 2 diabetes in adults. Although in the press it has gained popularity regarding weight-loss, it’s important to note that it is not approved for weight-loss by the FDA.
What is Mounjaro Injection?
Mounjaro is an FDA approved medication to reduce blood sugar levels in adults above the age of 18 with type 2 diabetes. It is a once-weekly injection that should be used in conjunction with diet and exercise.
Mounjaro & Weight Loss
Mounjaro can lead to significant weight loss in overweight patients with type 2 diabetes, however Mounjaro is not a weight loss drug and not approved for weight-loss.
How does Mounjaro work?
Mounjaro works by increasing insulin production, lowering sugar production by the liver, and slowing down food passage in the gut.
Mounjaro Side Effects & Restrictions
Common side effects of Mounjaro include:
Mounjaro can also cause more serious side effects including pancreatitis, kidney failure and thyroid disorders. It is important to consult with your doctor, any treatment plans they may involve Mounjaro.
Before using MOUNJARO, tell your healthcare provider about all of your medical conditions, including if you:
Mounjaro is available at Clemenceau Medical Center Hospital Dubai. Mounjaro should only be taken as indicated following a consultation with a Doctor
Mounjaro is injected subcutaneously, usually once a week, and can be administered in the abdomen, thigh, or upper arm.